课题基金 / 基金详情

Identification of primary molecule leading to aminoglycoside-induced nephrotoxicity and optimization of molecular-targeted approach for preventing aminoglycoside toxicity

Identification of primary molecule leading to aminoglycoside-induced nephrotoxicity and optimization of molecular-targeted approach for preventing aminoglycoside toxicity
导致氨基糖苷类肾毒性的主要分子的鉴定以及预防氨基糖苷类毒性的分子靶向方法的优化
批准号:
23590182
负责人:
NAGAI Junya
金额:
$3.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2013

项目摘要

项目成果

NAGAI Junya的其他基金

相似基金

相关文献

中文摘要
翻译
在这项研究中,我们研究了氨基糖苷类抗生素庆大霉素进入肾近端小管细胞系OK和HK-2的分子机制。在表达多配体内吞受体megalin的OK细胞中,庆大霉素是通过依赖内吞作用的途径进入细胞的。另一方面,在只有少量megalin表达的HK-2细胞中,参与庆大霉素摄取的途径不是内吞作用,而是内吞作用依赖途径。此外,研究还表明,HK-2细胞对庆大霉素的非内吞摄取至少部分是通过TRPV阳离子通道转运的。当庆大霉素通过通道依赖的途径进入肾小管细胞时,庆大霉素直接进入细胞质,在那里庆大霉素有效地影响线粒体功能,导致细胞死亡。综上所述,TRPV阳离子通道活性的激活可能会增加氨基糖苷类药物引起的肾毒性的风险。
英文摘要
In this study, we investigated the molecular mechanisms underlying entry of an aminoglycoside antibiotic gentamicin in renal proximal tubular cell lines OK and HK-2. In OK cells expressing a multi-ligand endocytic receptor megalin, gentamicin was taken up into the cells via endocytosis-dependent pathway. On the other hand, in HK-2 cells with little megalin expression, endocytosis-independent pathway, but not endocytosis-dependent pathway, was shown to be involved in gentamicin uptake. In addition, it was suggested that the endocytosis-independent uptake of gentamicin in HK-2 cells is, at least in part, due to transport via TRPV cation channel. When gentamicin is transported via a channel-dependent pathway into renal tubular cells, gentamicin directly enters the cytoplasm, where gentamicin potently affects mitochondrial function leading to cell death. Taken together, it is likely that activation of TRPV cation channel activity increases the risk of aminoglycoside-induced nephrotoxicity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effect of gadolimium on endocytic uptake of albumin in cultured human renal proximal tubular epithelial cells.
钆对培养的人肾近端肾小管上皮细胞白蛋白内吞摄取的影响。
DOI: --
发表时间: 2013
期刊: Current Topics in Pharmacology
影响因子: --
作者: [Nagai J, Kimura M, Okada Y, Yumoto R, Takano M.]
通讯作者: Takano M.
Receptor-targeted prevention of aminoglycoside accumulation and toxicity in the kidney
受体靶向预防氨基糖苷类药物在肾脏中的蓄积和毒性
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [M. Hult, G. Marissens, N. Sahin, M. Hoshi, H. Hasai, K. Shizuma, K. Tanaka, S. Endo, Junya Nagai]
通讯作者: Junya Nagai
培養ヒト腎近位尿細管上皮細胞におけるMRP2 mRNAのcAMP依存性発現誘導の機構解明
培养人肾近端肾小管上皮细胞中cAMP依赖性诱导MRP2 mRNA表达的机制
DOI: --
发表时间: 2014
期刊:
影响因子: --
作者: [長弘真知, 永井純也, 松崎翔太, 田邊敬明, 湯元良子, 高野幹久]
通讯作者: 高野幹久
培養腎上皮細胞OKにおけるプロタミンの取り込み特性
培养肾上皮细胞鱼精蛋白的摄取特性 OK
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [米田卓司, 永井純也, 湯元良子, 高野幹久]
通讯作者: 高野幹久
22
    Molecular mechanisms underlying HIF-1 activation by fatty acid-bearing albumin and renal protective effect by its regulation
    Pharmacokinetics of IgG and FcRn expression under normal and disease conditions
    • 批准号:
      21790150
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.75万
    • 财政年份:
      2009
    • 负责人:
      NAGAI Junya
    • 依托单位:
    Pharmacokinetic properties of vitamin-binding proteins and these application to vector for drug delivery
    • 批准号:
      19790126
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.34万
    • 财政年份:
      2007
    • 负责人:
      NAGAI Junya
    • 依托单位:
    海外基金